These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9744343)

  • 1. Remotely pollable Geiger-Müller detector for continuous monitoring of iodine-131 therapy patients.
    Zuckier LS; Boardman B; Zhao QH
    J Nucl Med; 1998 Sep; 39(9):1558-62. PubMed ID: 9744343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
    Al-Haj AN; Lagarde CS; Lobriguito AM
    Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation safety considerations for post-iodine-131 thyroid cancer therapy.
    Culver CM; Dworkin HJ
    J Nucl Med; 1992 Jul; 33(7):1402-5. PubMed ID: 1613585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models.
    Willegaignon J; Guimarães MI; Stabin MG; Sapienza MT; Malvestiti LF; Marone MM; Sordi GM
    Health Phys; 2007 Dec; 93(6):678-88. PubMed ID: 17993848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
    Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
    Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darwin: dose monitoring system applicable to various radiations with wide energy ranges.
    Sato T; Satoh D; Endo A; Yamaguchi Y
    Radiat Prot Dosimetry; 2007; 126(1-4):501-5. PubMed ID: 17496301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation safety considerations for post-iodine-131 hyperthyroid therapy.
    Culver CM; Dworkin HJ
    J Nucl Med; 1991 Jan; 32(1):169-73. PubMed ID: 1988627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiometabolic therapy: dose equivalents from external exposure and internal contamination].
    Scielzo G; Rivolta A
    Radiol Med; 1998 Jun; 95(6):663-8. PubMed ID: 9717552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy.
    Marriott CJ; Webber CE; Gulenchyn KY
    Radiat Prot Dosimetry; 2007; 123(1):62-7. PubMed ID: 16825250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance assessment and uncertainty evaluation of a portable NaI-based detection system used for thyroid monitoring.
    Bento J; Martins B; Teles P; Neves M; Colarinha P; Alves F; Teixeira N; Vaz P; Zankl M
    Radiat Prot Dosimetry; 2012 Aug; 151(2):252-61. PubMed ID: 22345216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital discharge of patients with thyroid carcinoma treated with 131I.
    Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
    J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the PGNAA using the LaBr3 scintillation detector.
    Favalli A; Mehner HC; Ciriello V; Pedersen B
    Appl Radiat Isot; 2010; 68(4-5):901-4. PubMed ID: 19884018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telematic system for monitoring of asthma severity in patients' homes.
    Finkelstein J; Hripcsak G; Cabrera M
    Stud Health Technol Inform; 1998; 52 Pt 1():272-6. PubMed ID: 10384460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
    Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
    Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new proposal for monitoring patients in nuclear medicine.
    Willegaignon J; Guimarães MI; Sapienza MT; Stabin MG; Malvestiti LF; Marone M; Sordi GM
    Health Phys; 2006 Dec; 91(6):624-9. PubMed ID: 17099406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
    Coover LR; Silberstein EB; Kuhn PJ; Graves MW
    J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is the post-therapeutic dosimetry of patients with short-term hospitalization after 131I therapy sufficiently reliable?].
    Körber C; Schneider P; Hänscheid H; Köck PR; Reiners C
    Nuklearmedizin; 2000; 39(1):9-12. PubMed ID: 10726251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study and implementation of a computerized program for personalized prescriptions for patients treated with radioiodine to be discharged].
    Puccini S; Traino AC; Ferdeghini M; Bodei L; Lazzeri M
    Radiol Med; 1999 Apr; 97(4):279-85. PubMed ID: 10414262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.